Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle

Author's Avatar
Jul 18, 2022

Tel Aviv, July 18, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s subsidiary, Cannovation Center Israel Ltd, has filed a provisional patent application in the United States Patent and Trademark Office (USPTO) for the treatment, amelioration, alleviation, mitigation, or balance of side effects in the oral cavity associated with the use of medicines, treatments, aging or unbalanced/unhealthy lifestyle.